person
Berthold S.
- Country
- Germany
- Department
- 402: Klinik für Augenheilkunde
Research Overview
assignment
8
Clinical Trials ·
- Cenegermin Ophthalmic Solution for the Treatment of Persistent Corneal Epithelial Defect: Phase 3 Randomized, Double-Masked, Vehicle-Controlled Study
- Phase III Double-Blind, Randomized, Placebo-Controlled Trial of Intravenous Tenecteplase for Visual Recovery in Acute Non-Arteritic Central Retinal Artery Occlusion
- Phase 3 Evaluation of Ripasudil (K-321) Eye Drops on Visual Acuity Post-Descemetorhexis in Fuchs Endothelial Corneal Dystrophy Patients
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
47
Sites with multiple studies
Has run more than one trial at 47 of 144 partner sites.
Specializations
Pediatric Eye Care
This investigator specializes in treating myopia progression in children, exploring innovative therapeutic approaches through eye drop treatments for vision correction and prevention.
- Childhood myopia management
- Progressive vision deterioration
- Preventive eye care in pediatrics
Corneal Disorders
The investigator focuses on treating Fuchs Endothelial Corneal Dystrophy and Neurotrophic Keratopathy, implementing advanced therapeutic strategies for corneal conditions.
- Corneal dystrophy treatment
- Visual acuity improvement
- Keratopathy management
Retinal Diseases
Expertise extends to treating complex retinal conditions including Geographic Atrophy, Diabetic Macular Edema, and Central Retinal Artery Occlusion.
- Age-related macular degeneration
- Diabetic eye complications
- Acute retinal vessel disorders
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.